|
Printable version |
From: | "G Stolwyk" <stolwyk@wave.co.nz> |
Date: | Sun, 30 Sep 2001 12:45:44 +1200 |
Diversys is not a public listed company. It is
bluechip, ie. very highly regarded in the medical world!
Peptech will own up to 33.6% ( my previously
mentioned 36% was incorrect ) by paying installments in the next 2 years.
There is talk that Diversys may list on the Nasdaq
in 2003.
The UK Medical
Research Council ( MRC ) is a major
shareholder and Greg Winter and his colleagues did their pioneering work
at the MRC's Laboratory of Molecular Biology ( LMB) in Cambridge ( U K
).
Normally, there are no problems with accessing
Diversys' web site but I have not been able to over the last 3 days or
so.
Gerry
|
|